Gerald Hecken-Meissner joined GMP-Orphan in 2018. He brings more than 30 years of international pharmaceutical industry experience in commercialization, market access, strategic and business development.
Most recently he served as General Manager Germany, Austria, Switzerland, CEE at Raptor Pharmaceuticals (acquired by Chiesi) where he led the founding and build-up of the complete business and organization. Prior to Raptor/Chiesi he managed the establishment and commercial set-up of the European Business at Pharmion, later acquired by Celgene. In a period of 15 years before this he had been working in a number of cross-functional management positions at national and international levels for amongst others Bayer AG.
Gerald is a qualified Business Management expert trained in Cologne and Harvard.